BTIG Maintains Their Hold Rating on Masimo (MASI)
In a report released today, Marie Thibault from BTIG maintained a Hold rating on Masimo (MASI). The company’s shares closed last Wednesday at $276.27, close to its 52-week high of $284.86.
According to TipRanks.com, Thibault is a 5-star analyst with an average return of 73.7% and a 71.8% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Varian Medical Systems, and Edwards Lifesciences.
Currently, the analyst consensus on Masimo is a Moderate Buy with an average price target of $278.00.
See today’s analyst top recommended stocks >>
The company has a one-year high of $284.86 and a one-year low of $143.90. Currently, Masimo has an average volume of 317.8K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.